Funding for this research was provided by:
Associazione Italiana per la Ricerca sul Cancro (ID. 21091 program)
Agenzia Italiana del Farmaco, Ministero della Salute (FPRC 5xmille 2015 - strategy)
Received: 14 December 2021
Accepted: 23 March 2022
First Online: 3 May 2022
: The study was approved by the local Ethics Committee who waived the requirement to obtain informed consent as only de-identified completely anonymised data were used.
: Not applicable.
: The authors declare that they have no competing interests.